Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients

ConclusionsOur data strengthen FTY effectiveness in everyday clinical practice, even in patients switching from NTZ treatment. Baseline parameters of inflammatory activity are the most important prognostic factors for mid-term disease reactivation also during second-line treatment with FTY, providing hints on how to select therapies towards a more personalized management.

http://link.springer.com/10.1007/s00415-018-8791-1

Source: Journal of Neurology - February 12, 2018 Category: Neurology Source Type: research